157 related articles for article (PubMed ID: 38217030)
21. Deubiquitylase YOD1 regulates CDK1 stability and drives triple-negative breast cancer tumorigenesis.
Han Z; Jia Q; Zhang J; Chen M; Wang L; Tong K; He W; Zhang Y; Zhu W; Qin J; Wang T; Liu T; Ma Y; Chen Y; Zha S; Zhang C
J Exp Clin Cancer Res; 2023 Sep; 42(1):228. PubMed ID: 37667382
[TBL] [Abstract][Full Text] [Related]
22. Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.
Lee J; Lim B; Pearson T; Choi K; Fuson JA; Bartholomeusz C; Paradiso LJ; Myers T; Tripathy D; Ueno NT
Breast Cancer Res Treat; 2019 Jun; 175(2):339-351. PubMed ID: 30826934
[TBL] [Abstract][Full Text] [Related]
23. The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer.
Shen Y; Yang F; Zhang W; Song W; Liu Y; Guan X
Cell Physiol Biochem; 2017; 43(5):2047-2061. PubMed ID: 29059676
[TBL] [Abstract][Full Text] [Related]
24. NT5DC2 knockdown suppresses progression, glycolysis, and neuropathic pain in triple-negative breast cancer by blocking the EGFR pathway.
Sang R; Yu X; Xia H; Qian X; Yong J; Xu Y; Sun Y; Yao Y; Zhou J; Zhuo S
Mol Carcinog; 2024 Apr; 63(4):785-796. PubMed ID: 38289126
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of CDCA7 predicts poor prognosis and induces EZH2-mediated progression of triple-negative breast cancer.
Ye L; Li F; Song Y; Yu D; Xiong Z; Li Y; Shi T; Yuan Z; Lin C; Wu X; Ren L; Li X; Song L
Int J Cancer; 2018 Nov; 143(10):2602-2613. PubMed ID: 30151890
[TBL] [Abstract][Full Text] [Related]
26. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
27. CPNE1 mediates glycolysis and metastasis of breast cancer through activation of PI3K/AKT/HIF-1α signaling.
Cao J; Cao R; Liu Y; Dai T
Pathol Res Pract; 2023 Aug; 248():154634. PubMed ID: 37454492
[TBL] [Abstract][Full Text] [Related]
28. Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1.
Zhang Z; Cui Z; Xie Z; Li C; Xu C; Guo X; Yu J; Chen T; Facchinetti F; Bohnenberger H; Leong TL; Xie Y; Mao X; Zhao J
Transl Lung Cancer Res; 2021 Oct; 10(10):3995-4011. PubMed ID: 34858787
[TBL] [Abstract][Full Text] [Related]
29. Platelet isoform of phosphofructokinase promotes aerobic glycolysis and the progression of non‑small cell lung cancer.
Wang F; Li L; Zhang Z
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236133
[TBL] [Abstract][Full Text] [Related]
30. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197
[TBL] [Abstract][Full Text] [Related]
31. Circ_0000520 contributes to triple-negative breast cancer progression through mediating the miR-1296/ZFX axis.
Zhou Y; Ma G; Peng S; Tuo M; Li Y; Qin X; Yu Q; Kuang S; Cheng H; Li J
Thorac Cancer; 2021 Sep; 12(18):2427-2438. PubMed ID: 34324278
[TBL] [Abstract][Full Text] [Related]
32. Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin.
Shen H; Yan W; Yuan J; Wang Z; Wang C
J Exp Clin Cancer Res; 2019 Jun; 38(1):243. PubMed ID: 31174562
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA ANRIL promotes chemoresistance in triple-negative breast cancer via enhancing aerobic glycolysis.
Ma J; Zhao W; Zhang H; Chu Z; Liu H; Fang X; Tang D
Life Sci; 2022 Oct; 306():120810. PubMed ID: 35850243
[TBL] [Abstract][Full Text] [Related]
34. Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer.
Blomme A; Costanza B; de Tullio P; Thiry M; Van Simaeys G; Boutry S; Doumont G; Di Valentin E; Hirano T; Yokobori T; Gofflot S; Peulen O; Bellahcène A; Sherer F; Le Goff C; Cavalier E; Mouithys-Mickalad A; Jouret F; Cusumano PG; Lifrange E; Muller RN; Goldman S; Delvenne P; De Pauw E; Nishiyama M; Castronovo V; Turtoi A
Oncogene; 2017 Apr; 36(15):2116-2130. PubMed ID: 27775075
[TBL] [Abstract][Full Text] [Related]
35. Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer.
Liao L; Zhang YL; Deng L; Chen C; Ma XY; Andriani L; Yang SY; Hu SY; Zhang FL; Shao ZM; Li DQ
Cancer Res; 2023 Feb; 83(3):471-484. PubMed ID: 36484700
[TBL] [Abstract][Full Text] [Related]
36. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
[TBL] [Abstract][Full Text] [Related]
37. Glycolysis regulator PFKP induces human melanoma cell proliferation and tumor growth.
Chen C; Zhang X
Clin Transl Oncol; 2023 Jul; 25(7):2183-2191. PubMed ID: 36792847
[TBL] [Abstract][Full Text] [Related]
38. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
[TBL] [Abstract][Full Text] [Related]
39. Ubiquitin-specific protease 5 promotes bladder cancer progression through stabilizing Twist1.
Cai H; Ke ZB; Chen JY; Li XD; Zhu JM; Xue YT; Ruan ZT; Wang Z; Lin F; Zheng QS; Wei Y; Xue XY; Xu N
Oncogene; 2024 Mar; 43(10):703-713. PubMed ID: 38218898
[TBL] [Abstract][Full Text] [Related]
40. Depletion of SENP1 suppresses the proliferation and invasion of triple-negative breast cancer cells.
Wang Z; Jin J; Zhang J; Wang L; Cao J
Oncol Rep; 2016 Oct; 36(4):2071-8. PubMed ID: 27573572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
